13168-99-5

Basic information

• Product Name: 2-Butenoic acid, 4-methoxy-, methyl ester, (E)-
• CAS NO: 13168-99-5
• Molecular Formula: C6H10O3
• Molecular Weight: 130.144
• Mol File: 13168-99-5.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: 2-Butenoic acid, 4-methoxy-, methyl ester, (E)-(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Butenoic acid, 4-methoxy-, methyl ester, (E)-(13168-99-5)
• EPA Substance Registry System: 2-Butenoic acid, 4-methoxy-, methyl ester, (E)-(13168-99-5)

Safety Data

• Hazardous Substances Data: 13168-99-5(Hazardous Substances Data)

Usage

General Description

2-Butenoic acid, 4-methoxy-, methyl ester, (E)- is a chemical compound that is a methyl ester derivative of 4-methoxy-2-butenoic acid. It is a colorless liquid with a fruity odor, and it is commonly used as a flavoring agent in the food and beverage industry. It has also been studied for its potential use as an insect attractant in pest control. The compound is considered to have low toxicity, but further research is needed to fully understand its potential environmental and health impacts.

Upstream product

• 186581-53-3 diazomethane 
• 63968-74-1 (E)-4-methoxybut-2-enoic acid 
• 67-56-1 methanol 
• 1117-71-1 methyl-4-bromo-2-butenoate 
• 10312-83-1 methoxyacetaldehyde 
• 21204-67-1 methyl (triphenylphosphoranylidene)acetate 
• 104803-79-4 iodure du methylcarbethoxy-1 propene-2 yl-2 triphenylphosphonium 
• 201230-82-2 carbon monoxide 
• 627-41-8 propargyl alcohol methyl ether 
• 25665-54-7 methyl cis-4-methoxy-2-butenoate 

Relevant articles and documents

IDO INHIBITORS

There are disclosed compounds that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or inflammatory disorders utilizing the compounds of the invention.

INHIBITORS OF CARBONIC ANHYDRASE

The invention relates to a compound of formula (I) and to pharmaceutically acceptable salts and solvates thereof. The invention also relates to methods of treating glaucoma, ocular hypertension, age-related macular degeneration, diabetic macular edema, di

Wittig reactions in the presence of silica gel

Wittig reactions, of stable phosphorous ylids, when carried out in presence of silica gel, in hexane, provide a fast, efficient and simple method to obtain α:β unsaturated compounds in high yields and high purity.